Loading clinical trials...
Loading clinical trials...
A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy in Previously Untreated CLL/SLL
Conditions
Interventions
orelabrutinib
FCR/BR
+1 more
Start Date
July 24, 2024
Primary Completion Date
March 26, 2026
Completion Date
December 26, 2026
Last Updated
June 27, 2024
NCT06319456
NCT05920668
Lead Sponsor
Fei Li
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions